Fast and complete control of heartburn in on-demand rabeprazole (RAB) maintenance therapy in patients with nonerosive reflux disease (NERD)

被引:3
|
作者
Bytzer, P
Blum, AL
De Herdt, D
机构
关键词
D O I
10.1016/S0016-5085(03)81147-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A228 / A228
页数:1
相关论文
共 43 条
  • [1] On-demand rabeprazole therapy provides heartburn control in long-term management of nonerosive reflux disease (NERD)
    Bytzer, P
    Blum, AL
    De Herdt, D
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A227 - A227
  • [2] Maintenance therapy with continuous and on-demand rabeprazole (RAB) 20mg in uninvestigated gastroesophageal reflux disease
    Morgan, David G.
    O'Mahony, Michael F.
    O'Mahony, William F.
    Roy, Jean
    Dinniwell, Julie
    Camacho, Fernando
    Husein-Bhabha, Farah A.
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A174 - A174
  • [3] Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial
    Fass, Ronnie
    Vaezi, Michael F.
    Sharma, Prateek
    Yadlapati, Rena
    Hunt, Barbara
    Harris, Tom
    Smith, Neila
    Leifke, Eckhard
    Armstrong, David
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S272 - S273
  • [4] On-demand maintenance therapy in patients with esophagitis and non-erosive reflux disease (NERD): A prospective, randomized, crossover, comparative study of rabeprazole versus lansoprazole
    Sobrino-Faya, Miguel
    Iglesias-Rey, Marta
    Dominguez-Munoz, Enrique
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A177 - A177
  • [5] On-demand maintenance therapy with rabeprazole (RAB) 10 mg: an effective alternative to continuous therapy for patients with frequent gastroesophageal reflux symptomatic relapse
    Bour, B
    Chousterman, M
    Labayle, D
    Nalet, B
    Nouel, O
    Pariente, A
    Bonnot-Marlier, S
    Tocque, E
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A229 - A229
  • [6] Maintenance treatment of gastroesophageal reflux disease: An evaluation of continuous and on-demand therapy with rabeprazole 20 mg
    Morgan, David G.
    O'Mahony, Michael Fj
    O'Mahony, William F.
    Roy, Jean
    Camacho, Fernando
    Dinniwell, Julie
    Horbay, Gla
    Husein-Bhabha, Farah A.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 21 (12) : 820 - 826
  • [7] Treatment outcomes with rabeprazole (RAB) 20 mg vs placebo (Pbo) in overweight/obese patients with nonerosive reflux disease (NERD): Analysis of 2 us multicenter trials
    Jacobson, Brian C.
    Delemos, Byron
    Sun, Yijun
    Xiang, Jim
    Lococo, John
    Murthy, Anita
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A493 - A493
  • [8] On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice:: Effectiveness, health-related quality of life, and patient satisfaction
    Ponce, J
    Argüello, L
    Bastida, G
    Ponce, M
    Ortiz, V
    Garrigues, V
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 931 - 936
  • [9] On-Demand Therapy with Rabeprazole in Nonerosive and Erosive Gastroesophageal Reflux Disease in Clinical Practice: Effectiveness, Health-Related Quality of Life, and Patient Satisfaction
    Julian Ponce
    Lidia Argüello
    Guillermo Bastida
    Marta Ponce
    Vicente Ortiz
    Vicente Garrigues
    [J]. Digestive Diseases and Sciences, 2004, 49 : 931 - 936
  • [10] Significant heartburn relief after the first dose of rabeprazole sodium in non-erosive reflux disease (NERD) patients.
    Miner, P
    Sloan, S
    Filippone, J
    Zheng, M
    DeLoria, C
    Jokubaitis, L
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A19 - A19